Additionally, in cancer research, the most abundant adipokines, i.e., adiponectin and leptin, are gaining recognition as modifiable risk factors due to their links with obesity and obesity-related cancer [13]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.